Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Aleafia and Serruya Family to Enter Cannabis Retail Joint-Venture for Launch of One Plant™

GlobeNewswire September 25, 2018

Data Projects the Global Cannabis Market is Projected to Reach USD 31.4 Billion by 2012

PR Newswire September 24, 2018

Aphria Appoints Head of Investor Relations

Canada NewsWire September 21, 2018

Aphria's Australian-Based Partner Althea Lists on the ASX in AUD$19.65M IPO

Canada NewsWire September 20, 2018

Aphria signs supply agreements with all provinces and Yukon

Canada NewsWire September 20, 2018

Cannabis Stock Rally Continues Growth

Stockhouse Editorial September 19, 2018

Cannabis Titans: The “Big 3” to Descend on Frankfurt

Marc Davis September 18, 2018

Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders

GlobeNewswire September 17, 2018

Aphria Announces Director Resignation and Appointment

Canada NewsWire September 14, 2018

The NEW Cannabis Rally

Jeff Nielson September 13, 2018

Aphria Signs Wholesale Supply Agreement With Emblem Cannabis Corporation

Canada NewsWire September 12, 2018

Data Shows That Medical Cannabis is set to Dominate the North American Market by 2025

PR Newswire September 10, 2018

Aphria completes divestment of all U.S. cannabis assets with sale of remaining interest in Liberty Health Sciences

Canada NewsWire September 6, 2018

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria's Portfolio of Medical and Adult-Use Brands

Canada NewsWire September 5, 2018

Aphria partners with Schroll Medical in Denmark to produce organic medical cannabis for the worldwide market

Canada NewsWire September 4, 2018

50 Days to Canada's Legalization, Pot Stocks Surge

Stockhouse Editorial August 28, 2018

Data Shows the Cannabis Industry Could Create Over 467,000 Jobs by 2022

PR Newswire August 28, 2018

Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia's adult-use cannabis market

Canada NewsWire August 27, 2018

Aphria signs agreement with OCS to supply 59 SKUS for the adult-use market in Ontario

Canada NewsWire August 21, 2018

Legal Cannabis Sales Show Increased Growth Across North America

PR Newswire August 14, 2018